Hyderabad-based Indian Immunologicals to manufacture measles-rubella vaccine
Measles immunization directly contributes to the reduction of under-five child mortality
Stay updated with breaking news from Immunization Programme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Measles immunization directly contributes to the reduction of under-five child mortality
Hyderabad-based Indian Immunologicals Limited (IIL), a vaccine manufacturer has announced receipt of approval from Drugs Controller General of India (DCGI) and State Drug Control Administration for manufacture of Measles-Rubella (MR) Vaccine. This is the outcome of the Indo-Vietnam partnership,
The Hyderabad based company partnered with a Vietnamese firm to manufacture the MR vaccine. India saw over 8700 cases of measles; highest in last years, with maximum cases being reported from Maharashtra and Gujarat.
The MR vaccine of Indian Immunologicals is the outcome of Indo-Vietnam partnership, wherein IIL has partnered with Center for Research and Production of Vaccines and Biologicals, also called Polyvac in Vietnam
The U-WIN Project is created to centralize the database of immunization facilities, but there is no clarity about its purpose and objectives.